What is the long-term trend for Charles River Laboratories's stock issuance proceeds?

Over 4 years (2021 to 2025), Charles River Laboratories's stock issuance proceeds has grown at a -64.6% compound annual growth rate (CAGR), from $45.65M to $714K.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Charles River Laboratories CRL Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

RevvityRVTY

$5.44M+107%

Bio-Rad LaboratoriesBIO

$3.4M-20.9%

Medpace Holdings, Inc.MEDP

$12.67M-51.1%

TEC

Bio-TechneTECH

$29.96M+101%

Agilent TechnologiesA

$1M0.0%

Arrowhead ResearchARWR

$46.83M—

Other financials

Income statement

See full

Revenue$995.8M+1.2%

Gross profit$349.0M-3.5%

Operating income$119.9M+60.6%

Net income-$14.8M-158%

EPS (diluted)-$0.30-160%

Balance sheet

See full

Cash & equivalents$198.2M-14.5%

Total debt$3.1B+1.9%

Total equity$2.9B-7.9%

Total assets$7.7B+2.0%

Cash flow

See full

Operating cash flow$41.1M-76.1%

CapEx$55.9M-5.8%

Free cash flow-$14.8M-113%

Valuation

See full

Market cap$8.91B+10.3%

Enterprise value$11.79B+8.5%

P/S2.2×+0.2×

Profitability

See full

Gross margin84.7%—

Operating margin13%-2.4pp

Net margin-4.6%—

FCF margin9.7%-4.3pp

Returns & leverage

See full

Return on equity-6%—

Debt / equity1×+0.1×

Current ratio1.4×-0.1×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Charles River Laboratories's stock issuance proceeds?: Charles River Laboratories (CRL) reported stock issuance proceeds of $1.22M in Q1 2026.
What is the long-term trend for Charles River Laboratories's stock issuance proceeds?: Over 4 years (2021 to 2025), Charles River Laboratories's stock issuance proceeds has grown at a -64.6% compound annual growth rate (CAGR), from $45.65M to $714K.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.